» Articles » PMID: 21193285

Colon Carcinoma--classification into Right and Left Sided Cancer or According to Colonic Subsite?--Analysis of 29,568 Patients

Overview
Publisher Elsevier
Date 2011 Jan 4
PMID 21193285
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It is common to distinguish between right and left colon cancer (RCC and LCC). But, little is known about the influence of its exact location on the tumor stage and characteristics when considering the colonic subsite within the right or left colon.

Methods: During a five-year period, 29,568 consecutive patients were evaluated by data from the German multi-centered observational study "Colon/Rectal Carcinoma". Patients were split into 7 groups, each group representing a colonic subsite. They were compared regarding demographic factors, tumor stage, metastatic spread and histopathological characteristics.

Results: Analysis of tumor differentiation and histological subtype revealed a linear correlation to the ileocecal valve, supporting the right and left side classification model. However, cancers arising from the RCC's cecum (52.3%) and LCC's splenic flexure (51.0%) showed the highest proportion of UICC stage III/IV tumors and lymphatic invasion, whereas the RCC's ascending colon (46.5%) and LCC's descending (44.7%) showed the lowest, which supports a more complex classification system, breaking down the right and left sides into colonic subsites.

Conclusions: Age, tumor grade and histological subtype support the right and left side classification model. However, gender, UICC stage, metastatic spread, T and N status, and lymphatic invasion correlated with a specific colonic subsite, irrespective of the side. The classification of RCC or LCC provides a general understanding of the tumor, but identification of the colonic subsite provides additional prognostic information. This study shows that the standard right and left side classification model may be insufficient.

Citing Articles

Colorectal Cancer: A Brief and Simplified Analysis of a Complex Disease.

Petrov K, Ivanov I, Popovska S, Betova T, Kamburova Z Medicina (Kaunas). 2025; 60(12.

PMID: 39768914 PMC: 11727892. DOI: 10.3390/medicina60122034.


Prognostic and Molecular Characterization of Metastatic Transverse Colon Cancer: Insights From a Single-Center Retrospective Study.

Isik D, Kinikoglu O Cureus. 2024; 16(12):e75046.

PMID: 39629291 PMC: 11614356. DOI: 10.7759/cureus.75046.


Transverse colon cancer: a call for focused research in an understudied heterogenous disease.

Cann C, Dotan E J Gastrointest Oncol. 2024; 15(4):1981-1986.

PMID: 39279924 PMC: 11399872. DOI: 10.21037/jgo-24-312.


Oncologic safety of transverse colon cancer surgery without central vessel ligation of middle colic artery.

Yang I, Yoon S, Kim J, Lee K Surg Endosc. 2024; 38(10):6037-6045.

PMID: 39134716 DOI: 10.1007/s00464-024-11159-1.


Sidedness is not a prognostic factor in an unselected cohort of patients with colon cancer but prognosis for caecal carcinoma is worse - A multivariate analysis of a large single institution database.

Stelzner S, Mehdorn M, Puffer E, Bleyl D, Kittner T, Rhode P Int J Colorectal Dis. 2024; 39(1):27.

PMID: 38349566 PMC: 10864445. DOI: 10.1007/s00384-023-04590-8.